IND Enabling
Phase I
Phase II
Phase III
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Tmunity Therapeutics
Main focus: CAR-T cell therapies for the treatment of cancer
Company stage: Clinical
Diseases: Prostate cancer, lung cancer, and ovarian cancer, other undisclosed diseases.
Genome editing tool: Undisclosed
Funding stage: Private
Location: Philadelphia, PA, USA
Website: https://www.tmunity.com/
Pipeline:https://www.tmunity.com/pipeline
Tmunity Therapeutics is a privately held biotherapeutics company focused on developing the next generation of T cell therapies. Tmunity is working closely with the University of Pennsulvania, where the company was founded. The company is developing multiple different such as engineered T cell receptors, regulatory T cells and CAR-T cells.
